Sandy Spring Bank Alpine Immune Sciences, Inc. Transaction History

Sandy Spring Bank

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 09, 2020	SELL	$7.15 - $11.5 $1,787 - $2,875	-250 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$2.77 - $12.1 $692 - $3,025	250 New	250 $2,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

Stay updated on Sandy Spring Bank with notifications on news.